Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children

Journal of Endocrinological Investigation

Volumn 31, Issue 2, 2008, Pages 153-158

  Scire G ^a   Del Bianco, C ^a   Spadoni, G L ^a   Cianfarani, Stefano ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

GH deficiency; GH therapy; IGF 1; IGFBP 3

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGE; ANTHROPOMETRY; ARTICLE; BODY MASS; CANCER RISK; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MULTIPLE REGRESSION; PREDICTION; PUBERTY; SEX DIFFERENCE; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 42649111282     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345582     Document Type: Article

References (32)